Debulking before Initiation of Venetoclax Therapy in Untreated Patients with Chronic Lymphocytic Leukemia: Results from a Phase 3b Study

MLA

Ian W. Flinn, et al. “Debulking before Initiation of Venetoclax Therapy in Untreated Patients with Chronic Lymphocytic Leukemia: Results from a Phase 3b Study.” Blood, vol. 138, Nov. 2021, p. 3725. EBSCOhost, https://doi.org/10.1182/blood-2021-147258.

APA

Ian W. Flinn, Jay Courtright, Bertrand Anz, Brenda Chyla, David Andorsky, John Pesko, Jeff P. Sharman, Suzanne R. Fanning, Habte A. Yimer, Jason M. Melear, Kathryn S. Kolibaba, Sudhir Manda, Suman Kambhampati, Dingfeng Jiang, John M. Burke, Tamas Vizkelety, & Miguel Islas-Ohlmayer. (2021). Debulking before Initiation of Venetoclax Therapy in Untreated Patients with Chronic Lymphocytic Leukemia: Results from a Phase 3b Study. Blood, 138, 3725. https://doi.org/10.1182/blood-2021-147258

Chicago

Ian W. Flinn, Jay Courtright, Bertrand Anz, Brenda Chyla, David Andorsky, John Pesko, Jeff P. Sharman, et al. 2021. “Debulking before Initiation of Venetoclax Therapy in Untreated Patients with Chronic Lymphocytic Leukemia: Results from a Phase 3b Study.” Blood 138 (November): 3725. doi:10.1182/blood-2021-147258.